Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
Use as required, especially during competitions, intensive training, or demanding physical labor
These effects typically diminish over time with gradual dose titration and taking metformin with meals
What does this post say variations in LEP can do to hunger signals
The study sponsors were not involved in any stage of research design, execution, data analysis, manuscript preparation, or publication decisions
& Isikan, U